Zynex Inc (ZYXI) - Net Assets

Latest as of September 2025: $-41.37 Million USD

Based on the latest financial reports, Zynex Inc (ZYXI) has net assets worth $-41.37 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($45.32 Million) and total liabilities ($86.69 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Zynex Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $-41.37 Million
% of Total Assets -91.28%
Annual Growth Rate 60.92%
5-Year Change -37.19%
10-Year Change N/A
Growth Volatility 55885.72

Zynex Inc - Net Assets Trend (1999–2024)

This chart illustrates how Zynex Inc's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Zynex Inc for the complete picture of this company's asset base.

Annual Net Assets for Zynex Inc (1999–2024)

The table below shows the annual net assets of Zynex Inc from 1999 to 2024. For live valuation and market cap data, see Zynex Inc stock valuation.

Year Net Assets Change
2024-12-31 $35.71 Million -22.59%
2023-12-31 $46.13 Million -30.48%
2022-12-31 $66.36 Million -10.24%
2021-12-31 $73.92 Million +30.02%
2020-12-31 $56.85 Million +189.29%
2019-12-31 $19.65 Million +111.37%
2018-12-31 $9.30 Million +89.68%
2017-12-31 $4.90 Million +228.93%
2016-12-31 $-3.80 Million +6.61%
2015-12-31 $-4.07 Million -221.31%
2014-12-31 $-1.27 Million -126.13%
2013-12-31 $4.85 Million -59.78%
2012-12-31 $12.05 Million +18.89%
2011-12-31 $10.14 Million +23.93%
2010-12-31 $8.18 Million +9.29%
2009-12-31 $7.49 Million +56.81%
2008-12-31 $4.77 Million +31.97%
2007-12-31 $3.62 Million +180.98%
2006-12-31 $1.29 Million +192.09%
2005-12-31 $440.77K +117.24%
2004-12-31 $202.89K +144.00%
2003-12-31 $-461.11K +22.50%
2000-12-31 $-594.94K -243929.51%
1999-12-31 $244.00 --

Equity Component Analysis

This analysis shows how different components contribute to Zynex Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 3161213200.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $29.77 Million 83.38%
Common Stock $32.00K 0.09%
Other Components $5.90 Million 16.53%
Total Equity $35.71 Million 100.00%

Zynex Inc Competitors by Market Cap

The table below lists competitors of Zynex Inc ranked by their market capitalization.

Company Market Cap
Tesoro Minerals Corp.
V:TES
$2.62 Million
CVC Income & Growth Limited
LSE:CVCG
$2.62 Million
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS
IS:LINK
$2.62 Million
BPH Global Ltd
AU:BP8
$2.62 Million
Flexituff Ventures International Limited
NSE:FLEXITUFF
$2.61 Million
Redstone Resources Ltd
AU:RDS
$2.61 Million
Awilco Drilling PLC
OL:AWDR
$2.60 Million
Adeunis
PA:ALARF
$2.60 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zynex Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 46,129,000 to 35,708,000, a change of -10,421,000 (-22.6%).
  • Net income of 2,994,000 contributed positively to equity growth.
  • Dividend payments of 9,000 reduced retained earnings.
  • Share repurchases of 15,625,000 reduced equity.
  • Other factors increased equity by 2,219,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $2.99 Million +8.38%
Dividends Paid $9.00K -0.03%
Share Repurchases $15.62 Million -43.76%
Other Changes $2.22 Million +6.21%
Total Change $- -22.59%

Book Value vs Market Value Analysis

This analysis compares Zynex Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.08x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 5.65x to 0.08x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1998-12-31 $0.02 $0.09 x
1999-12-31 $0.09 $0.09 x
2000-12-31 $-249.35 $0.09 x
2001-12-31 $-603.78 $0.09 x
2002-12-31 $-6.47 $0.09 x
2003-12-31 $-0.04 $0.09 x
2004-12-31 $0.01 $0.09 x
2005-12-31 $0.02 $0.09 x
2006-12-31 $0.05 $0.09 x
2007-12-31 $0.12 $0.09 x
2008-12-31 $0.14 $0.09 x
2009-12-31 $0.22 $0.09 x
2010-12-31 $0.24 $0.09 x
2011-12-31 $0.30 $0.09 x
2012-12-31 $0.35 $0.09 x
2013-12-31 $0.14 $0.09 x
2014-12-31 $-0.03 $0.09 x
2015-12-31 $-0.12 $0.09 x
2016-12-31 $-0.11 $0.09 x
2017-12-31 $0.14 $0.09 x
2018-12-31 $0.25 $0.09 x
2019-12-31 $0.53 $0.09 x
2020-12-31 $1.48 $0.09 x
2021-12-31 $1.71 $0.09 x
2022-12-31 $1.70 $0.09 x
2023-12-31 $1.28 $0.09 x
2024-12-31 $1.11 $0.09 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zynex Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 8.38%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.56%
  • • Asset Turnover: 1.58x
  • • Equity Multiplier: 3.42x
  • Recent ROE (8.38%) is above the historical average (-1286.60%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1998 -13803.28% -135.65% 101.75x 1.00x $-16.85K
1999 -20821.31% -204.62% 101.75x 1.00x $-25.41K
2000 0.00% -1012.24% 1.10x 0.00x $-1.57 Million
2001 0.00% 0.00% 0.00x 0.00x $-33.92K
2002 0.00% 0.00% 0.00x 0.00x $1.37K
2003 0.00% -13.48% 2.51x 0.00x $-56.51K
2004 -480.98% -77.66% 1.59x 3.89x $-996.17K
2005 24.49% 4.78% 1.68x 3.05x $63.88K
2006 -24.88% -12.53% 0.92x 2.15x $-449.12K
2007 58.92% 26.48% 1.12x 1.98x $1.77 Million
2008 2.32% 0.94% 1.09x 2.26x $-366.46K
2009 31.82% 12.75% 1.57x 1.59x $1.63 Million
2010 4.28% 1.45% 1.53x 1.92x $-468.20K
2011 15.42% 4.58% 1.57x 2.15x $550.00K
2012 12.89% 3.92% 1.53x 2.15x $348.00K
2013 -149.55% -33.67% 1.26x 3.53x $-7.79 Million
2014 0.00% -55.76% 1.56x 0.00x $-6.08 Million
2015 0.00% -25.01% 3.15x 0.00x $-2.51 Million
2016 0.00% 0.52% 3.25x 0.00x $440.30K
2017 147.57% 31.43% 2.62x 1.79x $6.87 Million
2018 101.76% 29.93% 1.97x 1.72x $8.61 Million
2019 48.08% 20.87% 1.61x 1.43x $7.52 Million
2020 15.96% 11.33% 1.08x 1.31x $3.39 Million
2021 23.14% 13.13% 0.98x 1.80x $9.71 Million
2022 25.69% 10.78% 1.31x 1.81x $10.41 Million
2023 21.10% 5.28% 1.35x 2.97x $5.12 Million
2024 8.38% 1.56% 1.58x 3.42x $-576.80K

Industry Comparison

This section compares Zynex Inc's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $1,073,291,921
  • Average return on equity (ROE) among peers: -23.04%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Zynex Inc (ZYXI) $-41.37 Million -13803.28% N/A $2.61 Million
Accendra Health Inc (ACH) $565.23 Million -64.17% 7.24x $147.73 Million
Akso Health Group ADR (AHG) $17.27 Million -201.64% 0.83x $807.33 Million
Cardinal Health Inc (CAH) $54.00 Million 12.22% 2.53x $45.94 Billion
Cencora Inc. (COR) $75.30 Million 67.07% 19.61x $59.14 Billion
Cosmos Health Inc. (COSM) $-53.68K 0.00% 0.00x $10.83 Million
EDAP TMS SA (EDAP) $19.41 Million -151.12% 3.07x $126.31 Million
Empro Group Inc. Ordinary shares (EMPG) $1.41 Million 82.70% 1.73x $143.05 Million
Henry Schein Inc (HSIC) $3.66 Billion 0.00% 1.14x $8.70 Billion
McKesson Corporation (MCK) $6.27 Billion 15.35% 2.82x $99.71 Billion
Owens & Minor Inc (OMI) $70.80 Million 9.18% 1.18x $185.63 Million

About Zynex Inc

NASDAQ:ZYXI USA Medical Distribution
Market Cap
$2.61 Million
Market Cap Rank
#29382 Global
#5744 in USA
Share Price
$0.09
Change (1 day)
+7.50%
52-Week Range
$0.03 - $2.69
All Time High
$25.72
About

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more